Cannabis Tech的动态

Is your business prepared to deal with the potential fallout from the latest developments in US-China biopharma trade policy? Check out this approach for life science companies to navigate the uncertainty:?https://lnkd.in/e6je4EkQ #biosecure #blankettariffs

As trade policy is used more actively as a lever of U.S. foreign policy, biopharma companies must navigate the uncertainty in their supply chains.? Thank you Mile Iliev and Zachary Ogorzalek for summarizing what's happening and how our clients are dealing with it. Check out their approach: https://lnkd.in/ei26JRuG??

?????????????????? ?????????????? ?????????? ???????????? ??% ???? ??% ???? ?????? ?????????????? ?????? ???????? Non-oil domestic exports (Nodx) declined by 3.4% to approximately $42 billion in the first quarter of 2024, following a 1.4% decrease in the previous quarter, mainly attributed to fluctuating pharmaceutical demand. Read More: https://bityl.co/Q52U #singapore #singaporenews #singaporeexport #export #exportnews #exporting #news #BusinessNews #NewsUpdate #newsdaily #businessnewsupdates #InsightsSuccess

With the US-China tariff war showing every sign of worsening, multinational firms are considering building independent supply chains for the US and China. Leading pharmaceutical company AstraZeneca?has announced?plans to establish manufacturing plants in China to serve the region exclusively. But although forwarders are hopeful about the trend, its positive impacts may not be felt for some time, and there some obstacles ahead... Kimberley Estella C. reports. #chinaus #uschina #tradewar #tariffwar #protectionism #supplychain #logistics https://lnkd.in/ejRwf-yr

We invite you to watch our CEO Yoram Eshel presentation - Cracking the International Cannabis Logistics Chain Code. Discover practical strategies for overcoming hurdles. Explore the Global Cannabis Logistics Map for 2023 and get a sneak peek at the forecast for 2024. Dive into real-life case studies showcasing challenges faced in main lanes and the innovative solutions implemented. Learn valuable lessons from 2023 and gain insights into recommendations for 2024 and beyond, what to maintain, and where to improve. Don't miss out on this opportunity to crack the code with us! press on the link: https://lnkd.in/ddb2e3NR InternationalCBC #planning?#cannabis?#europe?#law?#health?#Cannabis?#logistics?#import?#export?#THC?#CBD?#supplychain?#qualityassurance?#security?#IMC?#GMP?#GDP?#hemp?#marijuana?#Israel?#cannabismedicinal?#cannabidiol?#cannabiscommunity?#cannabisindustry?#cannabisscience?#cannabiseducation?#transportation?#cannabistech?#recreationalcannabis?#medicalcannabis?#gsp?#consulting?#consultency?#insurance?#compliance?#inovation??#southafrica?#canada?#australia?#germany?#transportation?#landtransport?#shipping?#delivery?#customsclearance?#infarmed

Promising results from Ireland's life sciences sector! New data from the Central Statistics Office reveals a significant boost in goods exports, reaching €18.9bn in January—an impressive 22% increase from the same period last year. The surge in exports was largely driven by the medical and pharmaceutical products category, which saw a remarkable 48% jump to nearly €9bn. This sector accounted for a staggering 47.5% of all Irish exports during the month—a testament to Ireland's prominence in the global pharma industry. #IrishExports #EconomicGrowth #TradeSurplus https://lnkd.in/eNY-CZYd

Despite the restrictions, the banned Chinese companies might explore alternative strategies to maintain a presence in the US market. - Indirect Partnerships: Collaborating with third-party companies that do not fall under the restrictions could be one way to circumvent the ban. - Joint Ventures: Establishing joint ventures with non-Chinese firms to leverage their market access. - Local Manufacturing: Setting up manufacturing units in countries not subject to the US ban and exporting from there. ? https://lnkd.in/d52sF5TY

?? Carol Boyne Lynch, our Head of Customs and International Trade Services, is featured in today's Irish Independent, discussing the latest export figures released by the CSO (Central Statistics Office Ireland). Goods exports rose by 6% in the first half of 2024, with the total value reaching €107bn. While chemicals exports saw a significant increase of €3.7bn, medical and pharmaceutical exports experienced a 7% decline in June. Carol offers insights into these trends, highlighting the resilience and adaptability of Irish industries, especially the pharma sector's shift post-Covid. She also discusses the challenges posed by declining exports to the UK and the contrasting growth in the US market. ?? Read the full article here: https://lnkd.in/dxNpuc3j #BDOIreland #IrishTrade #Exports #CustomsAndTrade #IrishIndependent

Pharmaceuticals have mostly been spared from past tariff battles, but this time they’re on the block. For daily news and analysis subscribe to the?https://lnkd.in/gFNEJAhc newsletter. #Pharmaceuticals #Healthcare #Biotech

Irish exports have seen an increase of 10% this year compared to the same period of January to May in 2023. This phenomenal growth has been mainly attributed to the increased output of medical and pharmaceutical products in Ireland, which account for two-thirds of the State’s export trade. The continued rebound of the lifescience sector in Ireland this year and heading into 2025 is highly encouraging for the Irish economy. #lifescience #pharma #medicaldevice